Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies
Erica T. Goddard, Miles H. Linde, Shivani Srivastava, Grant Klug, Tamer B. Shabaneh, Santino Iannone, Candice Alexandra Grzelak, Sydney Marsh, Alessandra I. Riggio, Ryann E. Shor, Ian L. Linde, Marissa Guerrero, Joshua Veatch, Annelise G. Snyder, Alana L. Welm, Stanley R. Riddell, Cyrus M. Ghajar
Topics & Concepts
ImmunotherapyChimeric antigen receptorImmunologyAntigenImmune systemT cellMajor histocompatibility complexBiologyAdoptive cell transferCytotoxic T cellCancer researchIn vitroBiochemistryCAR-T cell therapy researchCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses